Page last updated: 2024-08-24

antineoplaston a10 and Bile Duct Cancer

antineoplaston a10 has been researched along with Bile Duct Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abukhiran, I; Bellizzi, AM; Dunseth, CD; Gosse, MD; Hornick, JL; Humble, RM; Isidro, RA; Pelletier, DJ; Varshney, N	1

Other Studies

1 other study(ies) available for antineoplaston a10 and Bile Duct Cancer

Article	Year
Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of Unknown Primary. The American journal of surgical pathology, 2023, 04-01, Volume: 47, Issue:4 Topics: Adenocarcinoma; Annexins; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Cholangiocarcinoma; Claudins; Humans; Neoplasms, Unknown Primary; Pancreatic Neoplasms; SOXB1 Transcription Factors	2023

Article

Year

Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of Unknown Primary.

The American journal of surgical pathology, 2023, 04-01, Volume: 47, Issue:4

Topics: Adenocarcinoma; Annexins; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Cholangiocarcinoma; Claudins; Humans; Neoplasms, Unknown Primary; Pancreatic Neoplasms; SOXB1 Transcription Factors

2023